RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Nathan J Bowen to Humans

This is a "connection" page, showing publications Nathan J Bowen has written about Humans.
Connection Strength

0.214
  1. Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, McDonald JF. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics. 2009 Dec 29; 2:71.
    View in: PubMed
    Score: 0.017
  2. Bowen NJ, Jordan IK. Exaptation of protein coding sequences from transposable elements. Genome Dyn. 2007; 3:147-162.
    View in: PubMed
    Score: 0.014
  3. Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB, McDonald JF. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 2007 Feb; 104(2):331-7.
    View in: PubMed
    Score: 0.013
  4. Bowen NJ, Palmer MB, Wade PA. Chromosomal regulation by MeCP2: structural and enzymatic considerations. Cell Mol Life Sci. 2004 Sep; 61(17):2163-7.
    View in: PubMed
    Score: 0.012
  5. Bowen NJ, Fujita N, Kajita M, Wade PA. Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta. 2004 Mar 15; 1677(1-3):52-7.
    View in: PubMed
    Score: 0.011
  6. Jordan IK, Bowen NJ. Computational analysis of transposable element sequences. Methods Mol Biol. 2004; 260:59-71.
    View in: PubMed
    Score: 0.011
  7. Li X, Chen Y, Bai L, Zhao R, Wu Y, Xie ZR, Wu JM, Bowen NJ, Danaher A, Cook N, Li D, Qui M, Du Y, Fu H, Osunkoya AO, Kucuk O, Wu D. Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models. Br J Cancer. 2023 09; 129(5):884-894.
    View in: PubMed
    Score: 0.011
  8. Bowen NJ, Jordan IK. Transposable elements and the evolution of eukaryotic complexity. Curr Issues Mol Biol. 2002 Jul; 4(3):65-76.
    View in: PubMed
    Score: 0.010
  9. Dougan J, Hawsawi O, Burton LJ, Edwards G, Jones K, Zou J, Nagappan P, Wang G, Zhang Q, Danaher A, Bowen N, Hinton C, Odero-Marah VA. Proteomics-Metabolomics Combined Approach Identifies Peroxidasin as a Protector against Metabolic and Oxidative Stress in Prostate Cancer. Int J Mol Sci. 2019 Jun 21; 20(12).
    View in: PubMed
    Score: 0.008
  10. Burton LJ, Hawsawi O, Sweeney J, Bowen N, Hudson T, Odero-Marah V. CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-a) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE). PLoS One. 2019; 14(4):e0214844.
    View in: PubMed
    Score: 0.008
  11. Elliott B, Millena AC, Matyunina L, Zhang M, Zou J, Wang G, Zhang Q, Bowen N, Eaton V, Webb G, Thompson S, McDonald J, Khan S. Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells. Cancer Lett. 2019 04 28; 448:155-167.
    View in: PubMed
    Score: 0.008
  12. Burton LJ, Hawsawi O, Loyd Q, Henderson V, Howard S, Harlemon M, Ragin C, Roberts R, Bowen N, Gacii A, Odero-Marah V. Association of Epithelial Mesenchymal Transition with prostate and breast health disparities. PLoS One. 2018; 13(9):e0203855.
    View in: PubMed
    Score: 0.008
  13. Sheng X, Bowen N, Wang Z. GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer. Mol Cancer. 2016 Mar 18; 15:25.
    View in: PubMed
    Score: 0.006
  14. Pannu V, Rida PC, Ogden A, Turaga RC, Donthamsetty S, Bowen NJ, Rudd K, Gupta MV, Reid MD, Cantuaria G, Walczak CE, Aneja R. HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients. Oncotarget. 2015 Mar 20; 6(8):6076-91.
    View in: PubMed
    Score: 0.006
  15. Chinaranagari S, Sharma P, Bowen NJ, Chaudhary J. Prostate cancer epigenome. Methods Mol Biol. 2015; 1238:125-40.
    View in: PubMed
    Score: 0.006
  16. Patel D, Knowell AE, Korang-Yeboah M, Sharma P, Joshi J, Glymph S, Chinaranagari S, Nagappan P, Palaniappan R, Bowen NJ, Chaudhary J. Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer. Mol Endocrinol. 2014 Aug; 28(8):1239-53.
    View in: PubMed
    Score: 0.006
  17. Pawar S, Donthamsetty S, Pannu V, Rida P, Ogden A, Bowen N, Osan R, Cantuaria G, Aneja R. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries. J Ovarian Res. 2014; 7:53.
    View in: PubMed
    Score: 0.006
  18. Liu Y, Bowen NJ, Matyunina L, McDonald J, Prausnitz MR. Gene transfection enhanced by ultrasound exposure combined with drug treatment guided by gene chip analysis. Int J Hyperthermia. 2012; 28(4):349-61.
    View in: PubMed
    Score: 0.005
  19. Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF. Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Mol Cell Biochem. 2012 Apr; 363(1-2):257-68.
    View in: PubMed
    Score: 0.005
  20. Huda A, Tyagi E, Mari?o-Ram?rez L, Bowen NJ, Jjingo D, Jordan IK. Prediction of transposable element derived enhancers using chromatin modification profiles. PLoS One. 2011; 6(11):e27513.
    View in: PubMed
    Score: 0.005
  21. Shahab SW, Matyunina LV, Mezencev R, Walker LD, Bowen NJ, Benigno BB, McDonald JF. Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach. PLoS One. 2011; 6(7):e22508.
    View in: PubMed
    Score: 0.005
  22. Huda A, Bowen NJ, Conley AB, Jordan IK. Epigenetic regulation of transposable element derived human gene promoters. Gene. 2011 Apr 01; 475(1):39-48.
    View in: PubMed
    Score: 0.004
  23. Liu Y, Chen Y, Momin A, Shaner R, Wang E, Bowen NJ, Matyunina LV, Walker LD, McDonald JF, Sullards MC, Merrill AH. Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry. Mol Cancer. 2010 Jul 12; 9:186.
    View in: PubMed
    Score: 0.004
  24. Wang J, Bowen NJ, Mari?o-Ram?rez L, Jordan IK. A c-Myc regulatory subnetwork from human transposable element sequences. Mol Biosyst. 2009 Dec; 5(12):1831-9.
    View in: PubMed
    Score: 0.004
  25. K?bel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, Santos J, Swenerton K, Gilks CB, Huntsman D. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 2008 Dec 02; 5(12):e232.
    View in: PubMed
    Score: 0.004
  26. Arakaki AK, Mezencev R, Bowen NJ, Huang Y, McDonald JF, Skolnick J. Identification of metabolites with anticancer properties by computational metabolomics. Mol Cancer. 2008 Jun 17; 7:57.
    View in: PubMed
    Score: 0.004
  27. Moreno CS, Matyunina L, Dickerson EB, Schubert N, Bowen NJ, Logani S, Benigno BB, McDonald JF. Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas. PLoS One. 2007 May 16; 2(5):e441.
    View in: PubMed
    Score: 0.003
  28. Menendez L, Walker D, Matyunina LV, Dickerson EB, Bowen NJ, Polavarapu N, Benigno BB, McDonald JF. Identification of candidate methylation-responsive genes in ovarian cancer. Mol Cancer. 2007 Jan 25; 6:10.
    View in: PubMed
    Score: 0.003
  29. Polavarapu N, Bowen NJ, McDonald JF. Newly identified families of human endogenous retroviruses. J Virol. 2006 May; 80(9):4640-2.
    View in: PubMed
    Score: 0.003
  30. Polavarapu N, Bowen NJ, McDonald JF. Identification, characterization and comparative genomics of chimpanzee endogenous retroviruses. Genome Biol. 2006; 7(6):R51.
    View in: PubMed
    Score: 0.003
  31. Arudchandran A, Cerritelli SM, Bowen NJ, Chen X, Krause MW, Crouch RJ. Multiple ribonuclease H-encoding genes in the Caenorhabditis elegans genome contrasts with the two typical ribonuclease H-encoding genes in the human genome. Mol Biol Evol. 2002 Nov; 19(11):1910-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support